Establishment and characterization of a new human prostatic cancer cell line: DuCaP.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  In Vivo

• Publication date

  2001-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 11317521
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 2000

  2000cited by this paper
• Rapid ("warm") autopsy study for procurement of metastatic prostate cancer.

  2000cited by this paper
• Molecular cytogenetic studies of a serially transplanted primary prostatic carcinoma xenograft (CWR22) and four relapsed tumors

  1999cited by this paper
• Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process.

  1999cited by this paper
• Establishment of two human prostate cancer cell lines derived from a single bone metastasis.

  1997cited by this paper
• Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23.

  1996cited by this paper
• Androgen-repressed phenotype in human prostate cancer.

  1996cited by this paper
• Management of cancer of the prostate.

  1994cited by this paper
• Carcinoma of the prostate.

  1991cited by this paper
• Cytokeratin characterization of human prostatic carcinoma and its derived cell lines.

  1987cited by this paper
• Immunoblotting and dot immunobinding--current status and outlook.

  1984cited by this paper
• LNCaP model of human prostatic carcinoma.

  1983cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• The MicroRNA miR-454 and the mediator complex component MED12 are regulators of the androgen receptor pathway in prostate cancer

  2025cites this paper
• Experimental in vitro, ex vivo and in vivo models in prostate cancer research

  2022cites this paper
• Cell Line Characteristics Predict Subsequent Resistance to Androgen Receptor-Targeted Agents (ARTA) in Preclinical Models of Prostate Cancer

  2022cites this paper
• MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP Inhibitors

  2021cites this paper
• Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer

  2021cites this paper
• Challenges, applications and future directions of precision medicine in prostate cancer – the role of organoids and patient‐derived xenografts

  2020cites this paper
• The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype

  2019cites this paper
• High-Content Monitoring of Drug Effects in a 3D Spheroid Model

  2017cites this paper
• Patient-Derived Xenograft Models of Prostate Cancer

  2017cites this paper
• Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer

  2016cites this paper
• Distinct outcomes of CRL–Nedd8 pathway inhibition reveal cancer cell plasticity

  2016cites this paper
• Cascade profiling of the ubiquitin-proteasome system in cancer

  2015cites this paper
• Putative Prostate Cancer Risk SNP in an Androgen Receptor‐Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites

  2015cites this paper
• Effect of simvastatin on castration-resistant prostate cancer cells

  2014cites this paper
• Functional characterisation of phosphodiesterase 4D7 in prostate cancer

  2014cites this paper
• Prostate cancer: the significance of the cAMP signalling pathway

  2014cites this paper
• Gene fusions by chromothripsis of chromosome 5q in the VCaP prostate cancer cell line

  2013cites this paper
• In vitro model systems to study androgen receptor signaling in prostate cancer.

  2013cites this paper
• Generation of a stepwise prostate carcinogenesis model. A study of epithelial to mesenchymal transition and malignant transformation of prostate primary epithelial cells

  2013cites this paper
• Anterior gradient 2 and 3 – two prototype androgen‐responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells

  2013cites this paper
• Stem cells and steroid metabolism in prostate cancer

  2012cites this paper
• Elucidating Zinc Distribution In Cancerous Prostate Cells Using Novel FRET Sensors

  2012cites this paper
• Aldo-keto Reductase Family 1 Member C3 (AKR1C3) Is a Biomarker and Therapeutic Target for Castration-Resistant Prostate Cancer

  2012cites this paper
• Advances in the preclinical testing of cancer therapeutic hypotheses

  2011cites this paper
• Advanced Models for Target Validation & Drug Discovery in Prostate Cancer

  2011cites this paper
• Methodology to investigate androgen-sensitive and castration-resistant human prostate cancer xenografts in preclinical setting.

  2011cites this paper
• Etablissement d'un nouveau modèle pérclinique de cancer de la prostate et identification de biomarqueurs de résistance au docetaxel

  2011cites this paper
• Gene Transfer Vectors Targeted to Human Prostate Cancer: Do We Need Better Preclinical Testing Systems?

  2010cites this paper
• An in vitro model for preclinical testing of endocrine therapy combinations for prostate cancer

  2010influential citation
• Overexpression of chromatin assembly factor‐1 (CAF‐1) p60 is predictive of adverse behaviour of prostatic cancer

  2009cites this paper
• A novel, spontaneously immortalized, human prostate cancer cell line, Bob, offers a unique model for pre‐clinical prostate cancer studies

  2009cites this paper
• Molecular imaging of prostate cancer.

  2009cites this paper
• TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis

  2009influential citation
• Xenograft Models of Human Prostate Cancer

  2007cites this paper
• A small chimeric promoter for high prostate‐specific transgene expression from adenoviral vectors

  2007cites this paper
• Plant-derived MINA-05 inhibits human prostate cancer proliferation in vitro and lymph node spread in vivo.

  2007cites this paper
• Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells.

  2006cites this paper
• The human PC346 xenograft and cell line panel: a model system for prostate cancer progression.

  2006cites this paper
• Cell lines used in prostate cancer research: a compendium of old and new lines--part 1.

  2005cites this paper
• Osteoblasts in prostate cancer metastasis to bone

  2005cites this paper
• [Preclinical models of prostate cancer].

  2005cites this paper
• Three-dimensional co-culture models to study prostate cancer growth, progression, and metastasis to bone.

  2005cites this paper
• Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.

  2005cites this paper
• Combined effects of radiotherapy and photodynamic therapy on an in vitro human prostate model.

  2004cites this paper
• Molecular characterization of human prostate carcinoma cell lines

  2003influential citation
• Skeletal Complications of Malignancy Supplement to Cancer Stromal Factors Involved in Prostate Carcinoma Metastasis to Bone

  2003cites this paper
• LuCaP 35: A new model of prostate cancer progression to androgen independence

  2003cites this paper
• The effect of bone-associated growth factors and cytokines on the growth of prostate cancer cells derived from soft tissue versus bone metastases in vitro.

  2003cites this paper
• Stromal factors involved in prostate carcinoma metastasis to bone

  2003cites this paper
• Spectral karyotype (SKY) analysis of human prostate carcinoma cell lines

  2003cites this paper
• EPN: A novel epithelial cell line derived from human prostate tissue

  2002cites this paper
• A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines.

  2002cites this paper
• Using protein microarrays to study cancer.

  2002cites this paper
• Proline-rich tyrosine kinase 2 regulates proliferation and differentiation of prostate cells.

  2002cites this paper
• Calcium signals in prostate cancer cells: specific activation by bone-matrix proteins.

  2000cites this paper